Landmark Bio signs manufacturing agreement with Galapagos
Under the agreement, Landmark Bio will be responsible for performing Good Manufacturing Practice (GMP) manufacturing of clinical trial…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Nov 23
Under the agreement, Landmark Bio will be responsible for performing Good Manufacturing Practice (GMP) manufacturing of clinical trial…
13 Oct 23
By adding the new expanded production line, AGC Biologics can now provide more plasmid material in high-quality and…
12 Oct 23
For the second cell therapy of BMS, Cellares will optimise, automate, and tech-transfer the additional CAR-T cell therapy…
10 Oct 23
The facility has been designed to accommodate a second module of production suites, which will play a crucial…
06 Oct 23
The acquisition will allow Sharp to provide a comprehensive, fully integrated solution for small-to-medium-scale sterile injectable services within…
04 Oct 23
The collaboration aims to facilitate KateTx's initial internal portfolio of gene therapy programmes focused on muscle and heart…
03 Oct 23
Baxter’s BioPharma Solutions business will be renamed Simtra BioPharma Solutions (Simtra), which will continue to same solutions and…
22 Sep 23
Situated in IDA Business Park in Clonshaugh, the site will serve as an international base for a line…
25 Aug 23
Eubiologics, a company specialising in the development and production of Euvichol, will oversee the bulk vaccine production, while…
24 Aug 23
The expansion significantly boosts cell therapy capabilities and serves as a complementary addition to suspension and adhesion viral…